When a Shareholder Dies: The Buyout Clause That Prevents a Company Freeze

Most shareholder agreements are written for the living. They deal with exits, deadlock and disputes between active owners. Fewer address the practical consequences of a shareholder's death. Yet in a small UK company, a death can do what a boardroom argument cannot: freeze decisions, expose the business to probate delay and introduce an unexpected owner.

The clause that prevents this is often called a cross-option agreement. It is sometimes folded into the shareholders' agreement and sometimes kept in a separate document. Where it is missing, the company may have to rely on its articles, the deceased shareholder's will and the goodwill of the personal representatives. That is not a comfortable position for directors, surviving shareholders or the family of the deceased.

What happens by default

Shares are property. On death, they pass according to the shareholder's will or, if there is no valid will, the intestacy rules. The personal representatives - executors or administrators - take control of the estate's assets, including the shares. In England and Wales, they usually need a grant of probate or letters of administration before they can deal with the shares. In Scotland, the equivalent is confirmation; in Northern Ireland, probate procedures differ.

The company's articles may allow the personal representatives to be registered as members or to transfer the shares. Under the model articles for private companies limited by shares, a person entitled by transmission may need to be registered before exercising member rights, and the practical position depends on the wording. The key point is that the company should not assume the shares can be voted or sold immediately. Probate can take months, particularly if the estate is complex or the will is disputed.

During that period, the company may be unable to obtain shareholder approval for reserved matters. If the deceased held a majority, the estate may control the vote once registered. If the deceased held a blocking stake, major decisions may stall. If the deceased was also a director, the board may lose quorum or find that bank mandates need updating. Day-to-day trading may continue, but strategic decisions can wait indefinitely.

Why a cross-option agreement is the usual solution

A cross-option agreement gives the surviving shareholders and the deceased shareholder's estate a way out. In its simplest form, the estate grants the surviving shareholders an option to buy the deceased's shares, and the surviving shareholders grant the estate an option to sell them. Either side can trigger the option on death, usually within a fixed period.

The agreement should set out the price or a valuation mechanism. Common approaches include a fixed price reviewed annually, a formula based on profits or net assets, or an independent expert determination. The mechanism should be clear enough to operate without a negotiation. It should also say who pays for the valuation and what happens if the parties disagree.

Funding is the second half of the solution. Many cross-options are backed by life insurance written in trust for the surviving shareholders or the company. The insurance proceeds provide the cash to buy the shares without draining the business. The trust arrangement matters: if the policy is not held correctly, the proceeds may fall into the deceased's estate or be taxed in an unintended way. Directors should take advice on the ownership and tax treatment of the policy, including inheritance tax and capital gains.

A cross-option is not the same as a compulsory transfer clause in the articles. Articles can require a deceased shareholder's shares to be offered to the other shareholders, but they rarely contain a workable price and funding mechanism. A shareholders' agreement can fill the gap, but it must be consistent with the articles. If the two documents conflict, the company may face exactly the dispute the clause was meant to avoid.

The articles are only part of the picture

Directors should review the articles and any shareholders' agreement together. Look for transfer restrictions, pre-emption rights, compulsory transfer provisions and the powers of personal representatives. Check whether the articles allow the company to require a transfer, who sets the price and whether the directors can refuse to register a buyer.

Then look beyond the share register. What decisions require shareholder approval? What is the board quorum? Who can operate the bank accounts? Is there key person insurance? Are there contracts that terminate on a change of control? A death can trigger all of these issues at once.

Practical steps for directors now

First, locate the constitutional documents. If the company has model articles and no shareholders' agreement, the default position may be thinner than the directors assume. Second, map the shareholdings. Identify who controls reserved matters and what would happen if a stake were frozen in probate.

Third, decide the commercial outcome. Do the survivors want to buy the shares, bring in the family, or sell the company? Fourth, put a cross-option in place if one is missing. Agree the trigger, the option period, the valuation method and the insurance. Fifth, review the life cover regularly. Sums assured can become inadequate as the business grows.

Sixth, check board continuity. Consider quorum provisions, alternate directors, delegated authority and bank mandates. Seventh, encourage shareholders to keep their wills up to date and to tell the company who their personal representatives will be. Eighth, document decisions. If a death has already occurred, do not act unilaterally. Take advice on the articles, the estate and the tax position before registering a transfer or exercising a vote.

If death has already happened

The immediate priorities are to establish who has authority, preserve the value of the business and avoid a dispute with the family. Ask for evidence of the grant when it is available. Check whether the articles permit the personal representatives to vote or transfer. Review any insurance policy and notify the insurer promptly. If the deceased held a key role, consider interim board arrangements.

A well-drafted cross-option does not remove the sadness of a death. It does remove the financial and governance uncertainty that can follow. For UK companies, that is a practical legacy worth arranging while everyone is still around to agree it.